Pleural mesothelioma is a rare and aggressive cancer that affects the pleura, which is the thin lining of tissue surrounding the lungs and lining the chest cavity. This type of cancer is primarily caused by exposure to asbestos fibers, typically occurring after prolonged inhalation or ingestion of asbestos particles. Asbestos exposure is the primary risk factor for developing pleural mesothelioma, with symptoms often taking decades to manifest after exposure.
The symptoms of pleural mesothelioma can include:
- Shortness of breath
- Chest pain
- Persistent cough
- Fatigue
- Unexplained weight loss
- Lumps under the skin on the chest
- Difficulty swallowing
- Hoarseness
Diagnosis of pleural mesothelioma typically involves imaging tests such as X-rays, CT scans, or MRIs, followed by a biopsy to confirm the presence of mesothelioma cells.
Treatment options for pleural mesothelioma may include surgery, chemotherapy, radiation therapy, and/or immunotherapy, depending on the stage of the cancer and the overall health of the patient. Unfortunately, pleural mesothelioma often carries a poor prognosis due to its aggressive nature and the difficulty of early detection. However, advancements in treatment options and therapies offer hope for improved outcomes and quality of life for patients diagnosed with this condition.
